無料プレビュー

LivaNova PLC (LIVN) · NASDAQ Global Select

プロフィール

LivaNova PLC is a global medical technology company that designs, develops, manufactures, markets, and sells cardiopulmonary and neuromodulation products and therapies. Cardiopulmonary products include heart-lung machines, oxygenators, perfusion tubing, autotransfusion systems, and cannulae used in cardiac surgery; neuromodulation products include the VNS Therapy System for drug-resistant epilepsy and treatment-resistant depression, and the aura6000 System for obstructive sleep apnea. The company operates through two reportable segments—Cardiopulmonary and Neuromodulation—and sells globally th

主要指標

株価: $76.62 (+0.94%)
時価総額: 42億ドル
PER（今期予想）: 17.6
PBR: 3.2
配当利回り: —
52週レンジ: $48.82 – $85.76
業種: Healthcare / Medical - Devices
上場: NASDAQ Global Select
構成銘柄: —

比較会社: ABT Abbott Laboratories、MDT Medtronic Plc、SYK Stryker Corporation、BSX Boston Scientific Corporation、EW Edwards Lifesciences Corporation、RMD ResMed Inc.、DXCM DexCom, Inc.、GEHC GE HealthCare Technologies Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-04 · 更新: 2026-10-09